Daré Bioscience, Inc. (NASDAQ: DARE), a purpose-driven health biotech company solely focused on closing the gap in women’s ...

NRG Therapeutics, a fast growing neuroscience company targeting a novel mechanism to address mitochondrial dysfunction, has ...

VANCOUVER, BC / ACCESS Newswire / December 1, 2025 / BioNxt Solutions Inc. ("BioNxt" or the "Company") (CSE:BNXT)(OTCQB:BNXTF)(FSE:BXT), a bioscience innovator specializing in advanced drug delivery ...

BitMine Immersion Technologies ("BitMine" or the "Company") a Bitcoin and Ethereum Network Company with a focus on the accumulation of crypto for long term investment, today announced BitMine crypto + ...

NRG Therapeutics Ltd. (“NRG”), an innovative neuroscience company targeting a novel mechanism to address mitochondrial dysfunction, is pleased to announce expansion of its team with the appointment of ...

Qlik®, a global leader in data integration, data quality, analytics, and artificial intelligence (AI), today announced new capabilities in Qlik Open Lakehouse that bring streaming ingestion and ...

OcuHealth, an emerging eye therapeutics start-up, has been announced as the overall winner of University College Dublin’s ...

SGT-212 has been granted FDA Rare Pediatric Disease and Fast Track designations - - SGT-212 is the only dual route gene therapy in development to treat Friedreich’s ataxia - CHARLESTOWN, Mass., Dec.

Experts shared their insights with Technology Networks, offering a glimpse into a future where automation and intelligence work hand in hand.

Reports Q3 2025 Revenues of $20.6M, Gross Margin of 58.4%, and Positive Cash Provided by OperationsCompany Expects to Refinance or Repay the Debt in the Fourth QuarterFourth Quarter 2025 Guidance ...

A Harvard-backed study now challenges schools, parents, and policymakers to rethink how students learn. The message is simple: real progress begins when students learn to question, analyse, and think ...